Global Gamma-Aminobutyric Acid Receptor Industry Insights: Market Size, Growth Analysis and Forecast

Report ID : 1321357 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Gamma-Aminobutyric Acid Receptor Industry is categorized based on Type (GABA-A Receptor, GABA-B Receptor, GABA-C Receptor) and Application (Anxiety Disorders, Epilepsy, Sleep Disorders, Muscle Spasticity, Alcohol Dependence) and End-User (Pharmaceutical Companies, Research Institutions, Academic Institutions, Biotechnology Companies) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The Gamma-Aminobutyric Acid Receptor Industry was worth $1.2 billion in 2023 and is forecasted to reach $2.5 billion by 2033, growing at a CAGR of 8.1% over the period 2024-2033. This report covers various segments and analyzes the key trends and factors influencing the market significantly.

Gamma-Aminobutyric Acid (GABA) receptor market is gaining importance within the larger scope of neuropharmacology and biochemistry. GABA receptors, which are part of the central nervous system, often inhibit neurons and thus piracy enforcement has always been a must in order to save the delicate balance between inhibition and excitation of the brain. Given the increasing concern around mental well-being, there has been an increased requirement for cognitive therapy which has led to the growth of this specialized market. The consequences of GABA receptor manipulation are not only relevant for anxiety and depression, but also several neurological disorders, therefore this market is of particular relevance in today’s healthcare.

The last few years have seen a surge in research directed towards the functional and structural characterization of the subtypes of GABA receptors which has been attributed to the progress in biotechnology medicine. This has translated into the creation of new therapeutic agents and approaches aimed at the improvement of GABAergic transmission thus bringing relief to patients with epilepsy and disorders of sleep and mood. As the market matures, pharmaceutical companies, researchers and practitioners become more interested in harnessing the therapeutic promise of GABA receptors. Gaining such insights into GABA receptor market trends, opportunities and competitive force helps the relevant businesses with business engagements in GABA receptor market which is becoming more complex and rapidly developing.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AbbVie Inc., Roche Holding AG, Eli Lilly and Company, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Horizon Therapeutics plc, Amgen Inc.
SEGMENTS COVERED	By Type - GABA-A Receptor, GABA-B Receptor, GABA-C Receptor By Application - Anxiety Disorders, Epilepsy, Sleep Disorders, Muscle Spasticity, Alcohol Dependence By End-User - Pharmaceutical Companies, Research Institutions, Academic Institutions, Biotechnology Companies By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Gamma-Aminobutyric Acid Receptor Industry Dynamics

The Gamma-Aminobutyric Acid Receptor Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Gamma-Aminobutyric Acid Receptor Industry

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Pfizer Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Roche Holding AG
• Eli Lilly and Company
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Horizon Therapeutics plc
• Amgen Inc.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved